BioGaia Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

BioGaia heeft een totaal eigen vermogen van SEK1.6B en een totale schuld van SEK0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk SEK1.9B en SEK285.1M. De EBIT BioGaia is SEK458.5M waardoor de rentedekking -13.9 is. Het heeft contanten en kortetermijnbeleggingen van SEK1.1B.

Belangrijke informatie

Verhouding schuld/eigen vermogen

SEK 0

Schuld

Rente dekkingsratio	-13.9x
Contant	SEK 1.11b
Aandelen	SEK 1.62b
Totaal verplichtingen	SEK 285.12m
Totaal activa	SEK 1.90b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Oct 29

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SEK1.5B ) BIOG B } overtreffen de korte termijn passiva ( SEK192.4M ).

Langlopende schulden: De kortetermijnactiva BIOG B ( SEK1.5B ) overtreffen de langetermijnschulden ( SEK92.8M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: BIOG B is schuldenvrij.

Schuld verminderen: BIOG B heeft de afgelopen 5 jaar geen schulden gehad.

Schuldendekking: BIOG B heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: BIOG B heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

BioGaia Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

BioGaia's (STO:BIOG B) Soft Earnings Don't Show The Whole Picture

Third quarter 2024 earnings released: EPS: kr0.36 (vs kr1.01 in 3Q 2023)

BioGaia AB (publ) to Report Q2, 2025 Results on Jul 18, 2025

Price target increased by 7.1% to kr150

Vice President of Marketing recently sold kr407k worth of stock

Executive VP & CFO recently sold kr11m worth of stock

Vice President of Marketing exercised options to buy kr579k worth of stock.

Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.80 in 2Q 2023)

BioGaia AB (publ) to Report Fiscal Year 2024 Results on Feb 12, 2025

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Third quarter 2021 earnings released

Price target increased to kr533

Second quarter 2021 earnings released: EPS kr2.71 (vs kr4.56 in 2Q 2020)

Consensus forecasts updated

BioGaia AB (publ) (OM:BIOG B) acquired remaining 8% stake in MetaboGen AB for SEK 11.4 million.

Vice President of RA & Legal recently bought kr103k worth of stock

First quarter 2021 earnings released